Filtered By:
Education: Residencies
Vaccination: Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 92 results found since Jan 2013.
Discovery of highly immunogenic spleen-resident FCGR3 < sup > + < /sup > CD103 < sup > + < /sup > cDC1s differentiated by IL-33-primed ST2 < sup > + < /sup > basophils
Cell Mol Immunol. 2023 May 29. doi: 10.1038/s41423-023-01035-8. Online ahead of print.ABSTRACTRecombinant interleukin-33 (IL-33) inhibits tumor growth, but the detailed immunological mechanism is still unknown. IL-33-mediated tumor suppression did not occur in Batf3-/- mice, indicating that conventional type 1 dendritic cells (cDC1s) play a key role in IL-33-mediated antitumor immunity. A population of CD103+ cDC1s, which were barely detectable in the spleens of normal mice, increased significantly in the spleens of IL-33-treated mice. The newly emerged splenic CD103+ cDC1s were distinct from conventional splenic cDC1s bas...
Source: Cellular and Molecular Immunology - May 28, 2023 Category: Molecular Biology Authors: Myeong-Ho Kang JungHyub Hong Jinjoo Lee Min-Suk Cha Sangho Lee Hye-Young Kim Sang-Jun Ha Yong Taik Lim Yong-Soo Bae Source Type: research
New-Onset Diabetes after COVID-19
J Clin Endocrinol Metab. 2023 May 19:dgad284. doi: 10.1210/clinem/dgad284. Online ahead of print.ABSTRACTThere is evidence suggesting that infection with SARS-CoV-2 can lead to several long-term sequelae including diabetes. This mini-review examines the rapidly evolving and conflicting literature on new-onset diabetes after COVID-19, which we term NODAC. We searched PubMed, MEDLINE, and medRxiv from inception until December 1, 2022 using both MeSH terms and free text words including "COVID-19," "SARS-CoV-2," "diabetes," "hyperglycemia," "insulin resistance," and "pancreatic β-cell." We also supplemented searches by examin...
Source: The Journal of Clinical Endocrinology and Metabolism - May 19, 2023 Category: Endocrinology Authors: Sun H Kim Ipsa Arora Daniel S Hsia William C Knowler Erin LeBlanc Eleftherios Mylonakis Richard Pratley Anastassios G Pittas Source Type: research
Egyptian hemodialysis patients' willingness to receive the COVID-19 vaccine booster dose: a multicenter survey
CONCLUSION: COVID-19 booster-dose hesitancy among HD patients in Egypt represents a major concern, is associated with vaccine hesitancy with respect to other vaccines and emphasizes the need to develop effective strategies to increase vaccine uptake.PMID:36862285 | PMC:PMC9979119 | DOI:10.1007/s40620-023-01586-z
Source: Journal of Nephrology - March 2, 2023 Category: Urology & Nephrology Authors: Hoda Mahmoud Mohammad Abdulaziz Marwa Ahmed Saleh Mohamed Essam Elrggal Mariam E Omar Shymaa A Hawash Ahmed Mohamed Naguib Attiya Karem Mohamed Salem Alaa Abdel-Aziz Sabry Source Type: research
Memory B cell diversity: from early generation to tissue residency and reactivation
This article is protected by copyright. All rights reserved.PMID:36811174 | DOI:10.1002/eji.202250085
Source: European Journal of Immunology - February 22, 2023 Category: Allergy & Immunology Authors: Laura Reusch Davide Angeletti Source Type: research
Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics: A Retrospective Provincial Cohort Study
CONCLUSIONS: People attending advanced CKD clinics and diagnosed with SARS-CoV-2 infection in the first 21 months of the pandemic had high case fatality and hospitalization rates. Fatality rates were significantly lower in those who were doubly vaccinated.PMID:36795940 | DOI:10.2215/CJN.0000000000000087
Source: Clinical Journal of the American Society of Nephrology : CJASN - February 16, 2023 Category: Urology & Nephrology Authors: Jian Roushani Doneal Thomas Matthew J Oliver Jane Ip Angie Yeung Yiwen Tang Kenneth Scott Brimble Adeera Levin Michelle A Hladunewich Rebecca Cooper Peter G Blake Source Type: research
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020
CONCLUSION: AESI background rates varied by database and demographics and fluctuated in March-December 2020, but most returned to pre-pandemic levels after May 2020. It is critical to standardize demographics and consider seasonal and other trends when comparing historical rates with post-vaccination AESI rates in the same database to evaluate COVID-19 vaccine safety.PMID:36404170 | DOI:10.1016/j.vaccine.2022.11.003
Source: Vaccine - November 20, 2022 Category: Allergy & Immunology Authors: Keran Moll Bradley Lufkin Kathryn R Fingar Cindy Ke Zhou Ellen Tworkoski Chianti Shi Shayan Hobbi Mao Hu Minya Sheng Jillian McCarty Shanlai Shangguan Timothy Burrell Yoganand Chillarige Jeff Beers Patrick Saunders-Hastings Stella Muthuri Kathryn Edwards Source Type: research
Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study
CONCLUSION: COVID-19 vaccination provides a strong protective effect against COVID-19 related hospital admission, in patients with and without comorbidity.PMID:35863935 | DOI:10.1016/j.vaccine.2022.06.011
Source: Vaccine - July 21, 2022 Category: Allergy & Immunology Authors: F A Niessen M J Knol S J M Hahn é VECTOR study group M J M Bonten P C J L Bruijning-Verhagen Source Type: research
Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study
CONCLUSION: Immigrants were less hesitant toward vaccinations than the host population, but vaccine hesitancy increased with time spent in France. The provision of appropriate information and awareness to facilitate critical thinking towards antivaccine theories is necessary for immigrants in France.PMID:35644674 | DOI:10.1016/j.vaccine.2022.05.041
Source: Vaccine - June 1, 2022 Category: Allergy & Immunology Authors: Sohela Moussaoui Simon Combes Gladys Ibanez Arnaud Gautier Bridget Relyea Nicolas Vignier Source Type: research
